During the recent session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 2.76 million, with the beta value of the company hitting 0.80. At the last check today, the stock’s price was $84.12, reflecting an intraday gain of 1.88% or $1.55. The 52-week high for the BSX share is $84.11, that puts it up 0.01 from that peak though still a striking 42.52% gain since the share price plummeted to a 52-week low of $48.35. The company’s market capitalization is $123.88B, and the average intraday trading volume over the past 10 days was 5.15 million shares, and the average trade volume was 5.60 million shares over the past three months.
Boston Scientific Corp. (BSX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.46. BSX has a Sell rating from 0 analyst(s) out of 15 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 13 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.59.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp. (NYSE:BSX) trade information
Boston Scientific Corp. (BSX) registered a 1.88% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.88% in intraday trading to $84.12, hitting a weekly high. The stock’s 5-day price performance is 0.34%, and it has moved by 7.18% in 30 days. Based on these gigs, the overall price performance for the year is 58.62%. The short interest in Boston Scientific Corp. (NYSE:BSX) is 11.02 million shares and it means that shorts have 2.24 day(s) to cover.
The consensus price target of analysts on Wall Street is $77, which implies a decrease of -9.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $48 and $118 respectively. As a result, BSX is trading at a discount of -40.28% off the target high and 42.94% off the low.
Boston Scientific Corp. (BSX) estimates and forecasts
Statistics show that Boston Scientific Corp. has outperformed its competitors in share price, compared to the industry in which it operates. Boston Scientific Corp. (BSX) shares have gone up 24.73% during the last six months, with a year-to-date growth rate more than the industry average at 17.07% against 13.00. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 18.00% this quarter and then jump 16.40% in the quarter after that. In the rating firms’ projections, revenue will increase 14.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 4.04B as predicted by 24 analyst(s). Meanwhile, a consensus of 24 analyst(s) estimates revenue growth to 4.27B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 3.53B and 3.73B respectively. In this case, analysts expect current quarter sales to grow by 14.40% and then jump by 14.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -2.05%. While earnings are projected to return 17.48% in 2024, the next five years will return 12.84% per annum.
BSX Dividends
Boston Scientific Corp. is due to release its next quarterly earnings on 2024-Oct-24. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Boston Scientific Corp. (NYSE:BSX)’s Major holders
Boston Scientific Corp. insiders own 0.18% of total outstanding shares while institutional holders control 92.86%, with the float percentage being 93.03%. FMR LLC is the largest shareholder of the company, while 1914.0 institutions own stock in it. As of 2024-06-30, the company held over 141.46 million shares (or 9.6337% of all shares), a total value of $10.89 billion in shares.
The next largest institutional holding, with 129.87 million shares, is of VANGUARD GROUP INC’s that is approximately 8.8444% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $10.0 billion.
